Literature DB >> 13680150

Aplastic anemia complicating systemic lupus erythematosus: successful management with cyclosporine.

N P Singh1, Anupam Prakash, Dheeraj Garg, Aman Makhija, Anjali Pathania, Nirupam Prakash, Samir Kubba, S K Agarwal.   

Abstract

Anemia is common with connective tissue disorders, but pancytopenia is rare. We report a 22-year-old female who presented with menorrhagia, seizures, anemia, leukocytosis, thrombocytopenia, pericardial effusion, positive ANA, and evidence of vasculitis on CT head scan and was diagnosed with systemic lupus erythematosus (SLE). After 7 months of remission, she was readmitted with menorrhagia and pancytopenia. Investigations revealed aplastic anemia. She survived on transfusion support for 6 weeks, during which period she received methylprednisolone and cyclophosphamide pulses, and phenytoin was omitted but to no avail. Cyclosporine (300 mg/day) was started and the aplastic anemia responded. After 4 months of therapy, the cyclosporine was gradually tapered over the next 2 months. The patient has been on 10 mg/day of prednisolone for the last 6 months. Aplastic anemia is rare in SLE and the response to immunosuppressants is variable, but here is a success story.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 13680150     DOI: 10.1007/s00296-003-0318-z

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  10 in total

1.  High-dose intravenous cyclophosphamide treatment of systemic lupus erythematosus-associated aplastic anemia.

Authors:  A Winkler; R W Jackson; D S Kay; E Mitchell; S Carmignani; G C Sharp
Journal:  Arthritis Rheum       Date:  1988-05

Review 2.  Immune suppression of hematopoiesis.

Authors:  M J Cline; D W Golde
Journal:  Am J Med       Date:  1978-02       Impact factor: 4.965

3.  Oral cyclosporin-A is effective treatment for untreated and also for previously immunosuppressed patients with severe bone marrow failure.

Authors:  M Hinterberger-Fischer; P Höcker; K Lechner; H Seewann; W Hinterberger
Journal:  Eur J Haematol       Date:  1989-08       Impact factor: 2.997

4.  Antithymocyte globulin for a patient with systemic lupus erythematosus complicated by severe pancytopenia.

Authors:  Y Morishita; Y Matsukawa; Y Kura; M Takei; Y Tomita; S Nishinarita; T Horie
Journal:  J Int Med Res       Date:  1997 Jul-Aug       Impact factor: 1.671

5.  Aplastic anemia complicating systemic lupus erythematosus: response to androgens in two patients.

Authors:  R B Stricker; M A Shuman
Journal:  Am J Hematol       Date:  1984-08       Impact factor: 10.047

6.  Antiepileptics and blood dyscrasias: a cohort study.

Authors:  S C Blackburn; A D Oliart; L A García Rodríguez; S Pérez Gutthann
Journal:  Pharmacotherapy       Date:  1998 Nov-Dec       Impact factor: 4.705

7.  Pure red cell aplasia, toxic dermatitis and lymphadenopathy in a patient taking diphenylhydantoin.

Authors:  P C Huijgens; L G Thijs; G J den Ottolander
Journal:  Acta Haematol       Date:  1978       Impact factor: 2.195

8.  Aplastic anaemia in systemic lupus erythematosus: a cellular immune mechanism?

Authors:  C Roffe; M R Cahill; A Samanta; S Bricknell; S T Durrant
Journal:  Br J Rheumatol       Date:  1991-08

9.  Inhibition of hematopoiesis by a plasma factor in a case of aplastic anemia associated with systemic lupus erythematosus.

Authors:  J A Marqués; H Rhim; A Distenfeld
Journal:  P R Health Sci J       Date:  1995-12       Impact factor: 0.705

10.  Aplastic anemia associated with systemic lupus erythematosus.

Authors:  S Sumimoto; M Kawai; Y Kasajima; T Hamamoto
Journal:  Am J Hematol       Date:  1991-12       Impact factor: 10.047

  10 in total
  6 in total

Review 1.  The initial presentation of systemic lupus erythematosis with aplastic anemia successfully treated with rituximab.

Authors:  Gholam-Hossein Alishiri; Amin Saburi; Noushin Bayat; Ali-Reza Saadat; Ehsan Saburi
Journal:  Clin Rheumatol       Date:  2011-10-21       Impact factor: 2.980

Review 2.  Lessons learned from bone marrow failure in systemic lupus erythematosus: Case reports and review of the literature.

Authors:  Erik Anderson; Bhakti Shah; Anne Davidson; Richard Furie
Journal:  Semin Arthritis Rheum       Date:  2017-12-08       Impact factor: 5.532

Review 3.  Aplastic anemia as a feature of systemic lupus erythematosus: a case report and literature review.

Authors:  Émilie Chalayer; Martine Ffrench; Pascal Cathébras
Journal:  Rheumatol Int       Date:  2014-10-30       Impact factor: 3.580

4.  Aplastic anemia associated with systemic lupus erythematosus in children - case report and review of the literature.

Authors:  Machiel van den Akker; Earl Silverman; Mohamed Abdelhaleem; Melanie Kirby-Allen
Journal:  Clin Case Rep       Date:  2014-10-06

5.  Acquired aplastic anemia complicated with anti-glomerular basement membrane disease successfully treated with immunosuppressive therapy: a case report.

Authors:  Kenji Matsui; Wataru Kamata; Yasuhiro Mochida; Kunihiro Ishioka; Hidekazu Moriya; Sumi Hidaka; Takayasu Ohtake; Yotaro Tamai; Shuzo Kobayashi
Journal:  BMC Nephrol       Date:  2022-04-07       Impact factor: 2.388

Review 6.  The Use of Cyclosporine A in Rheumatology: a 2016 Comprehensive Review.

Authors:  Cecilia Beatrice Chighizola; Voon H Ong; Pier Luigi Meroni
Journal:  Clin Rev Allergy Immunol       Date:  2017-06       Impact factor: 10.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.